AR044177A1 - Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona - Google Patents
Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinonaInfo
- Publication number
- AR044177A1 AR044177A1 ARP040101537A ARP040101537A AR044177A1 AR 044177 A1 AR044177 A1 AR 044177A1 AR P040101537 A ARP040101537 A AR P040101537A AR P040101537 A ARP040101537 A AR P040101537A AR 044177 A1 AR044177 A1 AR 044177A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- trans
- derivatives
- formula
- lactone
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- VDOXIAUNJCHYRC-UHFFFAOYSA-N 1,3-diphenylazetidin-2-one Chemical class O=C1C(C=2C=CC=CC=2)CN1C1=CC=CC=C1 VDOXIAUNJCHYRC-UHFFFAOYSA-N 0.000 abstract 3
- 125000000422 delta-lactone group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- UVEWQKMPXAHFST-UHFFFAOYSA-N n,1-diphenylmethanimine Chemical compound C=1C=CC=CC=1C=NC1=CC=CC=C1 UVEWQKMPXAHFST-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se refiere a los procesos para la preparación de trans-isómeros de derivados de la difenilazetidinona, utilizando una delta-lactona quiral. Asimismo se relaciona con los procesos para la preparación del delta-lactona quiral. Además se refiere a las composiciones farmacéuticas que incluyen los trans-isómeros de los derivados de la difenilazetidinona. Reivindicación 1: Un proceso para preparar transisómeros de la difenilazetidinona de la fórmula (1), como se muestra en los diseños que se acompañan, o una sal de los mismos, en donde R1 y R2 son idénticos o diferentes, y representan al hidrógeno, halógeno o a un grupo alcoxi, y R3 representa al hidrógeno, alquilo o a un grupo protector hidroxi, que comprende la reacción de una delta lactona quiral de la fórmula (2), como se muestra en los diseños que se acompañan, en donde R1 es lo que se ha definido precedentemente, con una difenil imina de la fórmula (3), en donde R2, y R3, son lo que se ha definido precedentemente, ante la presencia de una base fuerte.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN668DE2003 | 2003-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044177A1 true AR044177A1 (es) | 2005-08-24 |
Family
ID=33428285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101537A AR044177A1 (es) | 2003-05-05 | 2004-05-06 | Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1626954A2 (es) |
| CN (1) | CN1805926A (es) |
| AR (1) | AR044177A1 (es) |
| WO (1) | WO2004099132A2 (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
| CA2550215A1 (en) | 2003-12-23 | 2005-07-07 | Astrazeneca Ab | Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| WO2006060808A1 (en) * | 2004-12-03 | 2006-06-08 | Teva Pharmaceutical Industries Ltd. | Ezetimibe polymorphs |
| TW200726746A (en) | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
| JP2008540557A (ja) * | 2005-05-11 | 2008-11-20 | マイクロビア インコーポレーテッド | フェノール型４−ビフェニリルアゼチジン−２−オンの製造方法 |
| CA2609506A1 (en) * | 2005-05-25 | 2006-11-30 | Microbia, Inc. | Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
| SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
| AR057072A1 (es) | 2005-06-22 | 2007-11-14 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto |
| WO2007017705A1 (en) * | 2005-08-09 | 2007-02-15 | Glenmark Pharmaceuticals Limited | Process for the preparation of azetidinones |
| WO2008061238A2 (en) * | 2006-11-16 | 2008-05-22 | Ironwood Pharmaceuticals, Inc. | Processes for production of 4-biphenylyazetidin-2-ones |
| EP2128133A1 (en) | 2008-05-26 | 2009-12-02 | Lek Pharmaceuticals D.D. | Ezetimibe process and composition |
| WO2009147383A1 (en) * | 2008-06-02 | 2009-12-10 | Cipla Limited | Process for the synthesis of arformoterol |
| WO2010113175A2 (en) | 2009-04-01 | 2010-10-07 | Matrix Laboratories Ltd | Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe |
| PL231215B1 (pl) | 2011-06-15 | 2019-02-28 | Inst Chemii Organicznej Polskiej Akademii Nauk | Sposób wytwarzania podstawionych azetydynonów oraz związków pośrednich do ich syntezy |
| CN103086938A (zh) * | 2011-10-28 | 2013-05-08 | 沈阳药科大学 | 依泽替米贝的合成方法 |
| CN103121966A (zh) * | 2011-11-17 | 2013-05-29 | 重庆华邦胜凯制药有限公司 | 定向合成(4-氯苯基)-(吡啶-2-基)-甲醇的方法 |
| CN103204795B (zh) * | 2012-01-11 | 2016-12-14 | 重庆华邦胜凯制药有限公司 | 一种手性氮杂环丁酮类化合物的制备方法 |
| WO2013189646A1 (de) * | 2012-06-22 | 2013-12-27 | Henkel Ag & Co. Kgaa | Photolabile duftspeicherstoffe |
| CN104744331B (zh) * | 2013-12-31 | 2018-05-15 | 浙江九洲药业股份有限公司 | 一种依泽替米贝中间体的合成工艺 |
| CN107176920B (zh) * | 2017-04-19 | 2019-09-20 | 江苏恒盛药业有限公司 | 一种依泽麦布的合成新工艺 |
| CN108586373A (zh) * | 2018-06-22 | 2018-09-28 | 苏州市贝克生物科技有限公司 | 依折麦布中间体的合成方法 |
| CN110818606B (zh) * | 2018-08-08 | 2021-06-29 | 上海博志研新药物技术有限公司 | 依折麦布及其中间体的制备方法 |
| WO2025238768A1 (ja) * | 2024-05-15 | 2025-11-20 | Ｎｔｔ株式会社 | リチウム二次電池 |
| WO2025238757A1 (ja) * | 2024-05-15 | 2025-11-20 | Ｎｔｔ株式会社 | 二次電池 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
-
2004
- 2004-05-05 WO PCT/IB2004/001396 patent/WO2004099132A2/en not_active Ceased
- 2004-05-05 CN CNA2004800162566A patent/CN1805926A/zh active Pending
- 2004-05-05 EP EP04731224A patent/EP1626954A2/en not_active Withdrawn
- 2004-05-06 AR ARP040101537A patent/AR044177A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1805926A (zh) | 2006-07-19 |
| WO2004099132A3 (en) | 2005-03-24 |
| EP1626954A2 (en) | 2006-02-22 |
| WO2004099132A2 (en) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR044177A1 (es) | Proceso para la preparacion de trans-isomeros de derivados de la difenilazetidinona | |
| GT200300292A (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
| ES2190396T3 (es) | Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| BRPI0608604B8 (pt) | moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| GT200600518A (es) | Derivados de pirimidina | |
| CY1105162T1 (el) | Ενωσεις και η χρηση τους ως αναστολεις 5-ητ | |
| UY28333A1 (es) | Inhibidores de caspasa y sus usos. | |
| CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
| BRPI0407695A (pt) | compostos, processo para a preparação de um composto, composições farmacêuticas que compreendem o composto, utilização dos compostos e processo de tratamento para diabetes do tipo 2 | |
| UY27803A1 (es) | Derivados de benzoxazina y usos de los mismos. | |
| UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
| AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
| CY1108366T1 (el) | Βενζοσουλφονικο αλας της 7-(2-(4-(3-τριφθορομεθυλ-φαινυλ-1,2,3,6-τετραϋδρο-πυριδ-1-υλ)αιθυλ)ισοκινολινης, η παρασκευη του και η χρηση του στη φαρμακευτικη αγωγη | |
| AR074053A1 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), y composiciones farmaceuticas que los contienen | |
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| CR9182A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene | |
| NI200900147A (es) | Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| AR040133A1 (es) | Derivados de n-acilamino bencil eter | |
| PA8589801A1 (es) | Aminoalcoxiindoles | |
| BRPI0408204A (pt) | derivados de quinolinona/benzoxazinona e usos dos mesmos | |
| ECSP088257A (es) | Derivados de amida | |
| BRPI0416873A (pt) | derivados de benzoxazina e usos dos mesmos | |
| BRPI0508102A (pt) | inibidores de caspase e usos dos mesmos | |
| UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |